Media Release Nelson, New Zealand – 8 March 2024 – Kimer Med, a Nelson biotech start-up, announced it has signed a contract valued at up to USD$750,000 (NZD$1.3 million) with Battelle Memorial Institute (Battelle), the world’s largest independent, nonprofit research…
While standard antiviral therapies can suppress active viral replication, there’s no existing treatment that can eradicate latent infection, meaning there’s no cure for many prevalent viral diseases. Viral infection has a detrimental impact on human health and longevity There are…
New Zealand’s Infectious Disease Research Platform ‘Te Niwha’ has released a substantial report entitled “Likely future pandemic agents and scenarios: An epidemiological and public health framework”. The report was commissioned to support the Public Health Agency and other decision-makers involved…
Introduction: Apoptosis is a natural and necessary process that occurs in the human body. It is sometimes referred to as “programmed cell death” which is a helpful way to understand it, because apoptosis is a highly regulated, orderly and controlled…
Nelson, New Zealand – 27 Oct 2023 – Kimer Med co-founder and CEO, Rick Kiessig, was awarded Entrepreneur of the Year at the GEN NZ 2023 Entrepreneurial Ecosystem Awards held at GridAKL Futures Lab in Auckland last night. The awards…
The JC virus is one of those viruses that you’ll probably never hear about, until you find it that it might kill you! The JC virus was identified in 1965, and later named after the man whose brain it was…
Flaviviruses are a family of viruses that cause a range of serious human diseases such as Dengue fever, Zika virus fever and Japanese encephalitis. They are important to understand due to their impact on global health and the increasing frequency…
6th Asia Dengue Summit –15 & 16 June, Bangkok, Thailand Attended by Kimer Med’s Business Development Manager, Dr Mike Schmidt, the annual Dengue Summit presents an opportunity for Dengue researchers, health professionals and others in the field to come together…
Nelson, New Zealand – 7 June 2023 – Kimer Med, a Nelson, New Zealand-based biotech start-up developing broad-spectrum antiviral compounds, today announced that it had achieved two 100% positive results in tests against the priority viruses Dengue (DENV-2) and Zika (ZIKV). The…
It was brought to our attention that someone has made a bunch of somewhat pessimistic comments on a Stuff article (November 28) about Kimer Med. We encourage questions about our work, and we don’t mind a healthy dose of scepticism…